Adaptive Biotechnologies(ADPT)
Focus: Adaptive Biotechnologies is a Seattle-based diagnostics company focused on immune-driven disease detection and monitoring, operating at mid-cap scale with ~750 employees. The company leverages T-cell receptor sequencing technology to develop diagnostic and therapeutic solutions across oncology and infectious disease.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
14+4 this month
Stable — net +4 jobs in 30d
8 added, 4 removed. Backfill posture.
Should You Work at Adaptive Biotechnologies?
AI assessmentAdaptive is a scientifically rigorous but financially strained diagnostics innovator; suitable for researchers prioritizing technical depth and public-company stability over near-term growth or restructuring risk.
Why Work Here
- 72% R&D intensity signals deep commitment to innovation and scientific rigor, offering researchers meaningful technical challenges.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Early-stage
11 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$170M
Help build intelligence for Adaptive Biotechnologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.